Faculty profile

Marek Rola-Pleszczynski

ResearcherPediatrics/ImmunologyUniversité de Sherbrooke

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Université de Sherbrooke directory, so their courses may be missing. Find their university profile.

Marek Rola-Pleszczynski

Researcher

Pediatrics/Immunology

Health Sciences

Université de Sherbrooke

Sherbrooke, Quebec, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
No publications since 2020.
Principal investigator on 4 research grants (4 CIHR), most recently in 2015.
Supervisor on 1 trainee award (1 CIHR), most recently in 2011.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Asthma Gpcr Leukotriene Lipid Mediator Phosphatase Signaling

Latest papers

RPTPε promotes M2-polarized macrophage migration through ROCK2 signaling and podosome formation.
Journal of cell science · 2020
Regulation of platelet-activating factor-mediated interleukin-6 promoter activation by the 48 kDa but not the 45 kDa isoform of protein tyrosine phosphatase non-receptor type 2.
Cell & bioscience · 2019
Role of Protein Tyrosine Phosphatase Epsilon (PTPε) in Leukotriene D4-Induced CXCL8 Expression.
The Journal of pharmacology and experimental therapeutics · 2019

All 34 publications

Latest funding

Role of protein tyrosine phosphatase-epsilon in cysteinyl leukotriene receptor signaling
CIHR · 2015 · Nominated PI
$661,727
Regulation of obesity by inflammatory cytokines
CIHR · 2014 · Co-investigator
$720,623
Lipid mediators in the regulation of the inflammasome: relevance to type 2 diabetes
CIHR · 2011 · Supervisor
$90,000

All 7 grants and awards

34 publications.

RPTPε promotes M2-polarized macrophage migration through ROCK2 signaling and podosome formation.

Lapointe F, Turcotte S, Roy J, Bissonnette E, Rola-Pleszczynski M, Stankova J

Journal of cell science2020

DOI: 10.1242/jcs.234641 PMID: 31722979

Regulation of platelet-activating factor-mediated interleukin-6 promoter activation by the 48 kDa but not the 45 kDa isoform of protein tyrosine phosphatase non-receptor type 2.

Hamel-Côté G, Lapointe F, Véronneau S, Mayhue M, Rola-Pleszczynski M, Stankova J

Cell & bioscience2019

DOI: 10.1186/s13578-019-0316-9 PMID: 31289638

Role of Protein Tyrosine Phosphatase Epsilon (PTPε) in Leukotriene D4-Induced CXCL8 Expression.

Lapointe F, Turcotte S, Véronneau S, Rola-Pleszczynski M, Stankova J

The Journal of pharmacology and experimental therapeutics2019

DOI: 10.1124/jpet.118.255422 PMID: 30867226

Regulation of platelet-activating factor-induced interleukin-8 expression by protein tyrosine phosphatase 1B.

Hamel-Côté G, Lapointe F, Gendron D, Rola-Pleszczynski M, Stankova J

Cell communication and signaling : CCS2019

DOI: 10.1186/s12964-019-0334-6 PMID: 30832675

IL-33 Upregulates Cysteinyl Leukotriene Receptor Type 1 Expression in Human Peripheral Blood CD4+ T Lymphocytes.

Boudaud M, Turcotte S, Stankova J, Rola-Pleszczynski M

Journal of immunology (Baltimore, Md. : 1950)2018Senior author

DOI: 10.4049/jimmunol.1701463 PMID: 30242072

Regulation of platelet-activating factor-mediated protein tyrosine phosphatase 1B activation by a Janus kinase 2/calpain pathway.

Hamel-Côté G, Gendron D, Rola-Pleszczynski M, Stankova J

PloS one2017

DOI: 10.1371/journal.pone.0180336 PMID: 28686728

Constitutively active Stat5b signaling confers tolerogenic functions to dendritic cells of NOD mice and halts diabetes progression.

Zerif E, Maalem A, Gaudreau S, Guindi C, Ramzan M, Véroneau S, Gris D, Stankova J, Rola-Pleszczynski M, Mourad W, Dupuis G, Amrani A

Journal of autoimmunity2017

DOI: 10.1016/j.jaut.2016.09.001 PMID: 27634616

Deficiency of Interleukin-15 Confers Resistance to Obesity by Diminishing Inflammation and Enhancing the Thermogenic Function of Adipose Tissues.

Lacraz G, Rakotoarivelo V, Labbé SM, Vernier M, Noll C, Mayhue M, Stankova J, Schwertani A, Grenier G, Carpentier A, Richard D, Ferbeyre G, Fradette J, Rola-Pleszczynski M, Menendez A, Langlois MF, Ilangumaran S, Ramanathan S

PloS one2016

DOI: 10.1371/journal.pone.0162995 PMID: 27684068

Interleukin-15-mediated inflammation promotes non-alcoholic fatty liver disease.

Cepero-Donates Y, Lacraz G, Ghobadi F, Rakotoarivelo V, Orkhis S, Mayhue M, Chen YG, Rola-Pleszczynski M, Menendez A, Ilangumaran S, Ramanathan S

Cytokine2016

DOI: 10.1016/j.cyto.2016.01.020 PMID: 26868085

Impaired immune regulation after radioiodine therapy for Graves' disease and the protective effect of Methimazole.

Côté-Bigras S, Tran V, Turcotte S, Rola-Pleszczynski M, Verreault J, Rottembourg D

Endocrine2016

DOI: 10.1007/s12020-015-0832-2 PMID: 26701678

Something wrong or missing on this profile? Suggest a correction

Marek Rola-Pleszczynski

Research

Latest papers

Latest funding

RPTPε promotes M2-polarized macrophage migration through ROCK2 signaling and podosome formation.

Regulation of platelet-activating factor-mediated interleukin-6 promoter activation by the 48 kDa but not the 45 kDa isoform of protein tyrosine phosphatase non-receptor type 2.

Role of Protein Tyrosine Phosphatase Epsilon (PTPε) in Leukotriene D4-Induced CXCL8 Expression.

Regulation of platelet-activating factor-induced interleukin-8 expression by protein tyrosine phosphatase 1B.

IL-33 Upregulates Cysteinyl Leukotriene Receptor Type 1 Expression in Human Peripheral Blood CD4+ T Lymphocytes.

Regulation of platelet-activating factor-mediated protein tyrosine phosphatase 1B activation by a Janus kinase 2/calpain pathway.

Constitutively active Stat5b signaling confers tolerogenic functions to dendritic cells of NOD mice and halts diabetes progression.

Deficiency of Interleukin-15 Confers Resistance to Obesity by Diminishing Inflammation and Enhancing the Thermogenic Function of Adipose Tissues.

Interleukin-15-mediated inflammation promotes non-alcoholic fatty liver disease.

Impaired immune regulation after radioiodine therapy for Graves' disease and the protective effect of Methimazole.

Role of protein tyrosine phosphatase-epsilon in cysteinyl leukotriene receptor signaling

Regulation of obesity by inflammatory cytokines

Lipid mediators in the regulation of the inflammasome: relevance to type 2 diabetes

Leukotriene B4 in Leukocyte Functions

Leukotriene B4 in Leukocyte Functions

Regulation of PAF receptor function

AllerGen (Allergy, genes and environment network)

Frequent collaborators

Jana Stankova

Subburaj Ilangumaran

Alfredo Menendez

Sheela Ramanathan

Adel Schwertani

Elyse Bissonnette

Julie Fradette

Gerardo Ferbeyre

Marie-France Langlois

Abdelaziz Amrani

Gerardo Ferbeyre

Marek Rola-Pleszczynski

Research

Latest papers

Latest funding

RPTP&#x3b5; promotes M2-polarized macrophage migration through ROCK2 signaling and podosome formation.

Regulation of platelet-activating factor-mediated interleukin-6 promoter activation by the 48&#xa0;kDa but not the 45&#xa0;kDa isoform of protein tyrosine phosphatase non-receptor type 2.

Role of Protein Tyrosine Phosphatase Epsilon (PTP&#x3b5;) in Leukotriene D4-Induced CXCL8 Expression.

Regulation of platelet-activating factor-induced interleukin-8 expression by protein tyrosine phosphatase 1B.

IL-33 Upregulates Cysteinyl Leukotriene Receptor Type 1 Expression in Human Peripheral Blood CD4+ T Lymphocytes.

Regulation of platelet-activating factor-mediated protein tyrosine phosphatase 1B activation by a Janus kinase 2/calpain pathway.

Constitutively active Stat5b signaling confers tolerogenic functions to dendritic cells of NOD mice and halts diabetes progression.

Deficiency of Interleukin-15 Confers Resistance to Obesity by Diminishing Inflammation and Enhancing the Thermogenic Function of Adipose Tissues.

Interleukin-15-mediated inflammation promotes non-alcoholic fatty liver disease.

Impaired immune regulation after radioiodine therapy for Graves' disease and the protective effect of Methimazole.

Role of protein tyrosine phosphatase-epsilon in cysteinyl leukotriene receptor signaling

Regulation of obesity by inflammatory cytokines

Lipid mediators in the regulation of the inflammasome: relevance to type 2 diabetes

Leukotriene B4 in Leukocyte Functions

Leukotriene B4 in Leukocyte Functions

Regulation of PAF receptor function

AllerGen (Allergy, genes and environment network)

Frequent collaborators

Jana Stankova

Subburaj Ilangumaran

Alfredo Menendez

Sheela Ramanathan

Adel Schwertani

Elyse Bissonnette

Julie Fradette

Gerardo Ferbeyre

Marie-France Langlois

Abdelaziz Amrani

Gerardo Ferbeyre

RPTPε promotes M2-polarized macrophage migration through ROCK2 signaling and podosome formation.

Regulation of platelet-activating factor-mediated interleukin-6 promoter activation by the 48 kDa but not the 45 kDa isoform of protein tyrosine phosphatase non-receptor type 2.

Role of Protein Tyrosine Phosphatase Epsilon (PTPε) in Leukotriene D4-Induced CXCL8 Expression.